The APL is 1 kind of AML characterized by the balanced reciprocal translocation between the promyelocytic leukemia gene on chromosome 15 and the retinoic acid receptor α (RARα) gene on chromosome 17, and accounts for 10% to 15% of newly diagnosed AML each year. This evidence concerns the gene RARA and acute promyelocytic leukemia.